The name of this superfamily has been modified since the most recent official CATH+ release (v4_2_0). At the point of the last release, this superfamily was named:
"Laminin
".
FunFam 45630: Stabilin-2
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 13 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Low-density lipoprotein receptor activity GO:0005041
Combining with a low-density lipoprotein particle and delivering the low-density lipoprotein into the cell via endocytosis.
|
6 | Q8WWQ8 (/IDA) Q8WWQ8 (/IDA) Q8WWQ8 (/IDA) Q9NY15 (/IDA) Q9NY15 (/IDA) Q9NY15 (/IDA) |
Scavenger receptor activity GO:0005044
Combining with any modified low-density lipoprotein (LDL) or other polyanionic ligand and delivering the ligand into the cell via endocytosis. Ligands include acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, beta-amyloid fibrils, and advanced glycation end products (AGEs).
|
6 | Q8WWQ8 (/IDA) Q8WWQ8 (/IDA) Q8WWQ8 (/IDA) Q9NY15 (/IDA) Q9NY15 (/IDA) Q9NY15 (/IDA) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
6 | Q8WWQ8 (/IPI) Q8WWQ8 (/IPI) Q8WWQ8 (/IPI) Q9NY15 (/IPI) Q9NY15 (/IPI) Q9NY15 (/IPI) |
Protein disulfide oxidoreductase activity GO:0015035
Catalysis of the reaction: a protein with reduced sulfide groups = a protein with oxidized disulfide bonds.
|
6 | Q8WWQ8 (/NAS) Q8WWQ8 (/NAS) Q8WWQ8 (/NAS) Q9NY15 (/NAS) Q9NY15 (/NAS) Q9NY15 (/NAS) |
Low-density lipoprotein particle binding GO:0030169
Interacting selectively and non-covalently with a low-density lipoprotein particle, a lipoprotein particle that is rich in cholesterol esters and low in triglycerides, is typically composed of APOB100 and APOE, and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm.
|
6 | Q8WWQ8 (/IDA) Q8WWQ8 (/IDA) Q8WWQ8 (/IDA) Q9NY15 (/IDA) Q9NY15 (/IDA) Q9NY15 (/IDA) |
Hyaluronic acid binding GO:0005540
Interacting selectively and non-covalently with hyaluronic acid, a polymer composed of repeating dimeric units of glucuronic acid and N-acetyl glucosamine.
|
5 | Q8R4U0 (/ISS) Q8R4U0 (/ISS) Q8WWQ8 (/ISS) Q8WWQ8 (/ISS) Q8WWQ8 (/ISS) |
Low-density lipoprotein receptor activity GO:0005041
Combining with a low-density lipoprotein particle and delivering the low-density lipoprotein into the cell via endocytosis.
|
4 | Q8R4U0 (/ISO) Q8R4U0 (/ISO) Q8R4Y4 (/ISO) Q8R4Y4 (/ISO) |
Scavenger receptor activity GO:0005044
Combining with any modified low-density lipoprotein (LDL) or other polyanionic ligand and delivering the ligand into the cell via endocytosis. Ligands include acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, beta-amyloid fibrils, and advanced glycation end products (AGEs).
|
4 | Q8R4U0 (/ISO) Q8R4U0 (/ISO) Q8R4Y4 (/ISO) Q8R4Y4 (/ISO) |
Low-density lipoprotein particle binding GO:0030169
Interacting selectively and non-covalently with a low-density lipoprotein particle, a lipoprotein particle that is rich in cholesterol esters and low in triglycerides, is typically composed of APOB100 and APOE, and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm.
|
4 | Q8R4U0 (/ISO) Q8R4U0 (/ISO) Q8R4Y4 (/ISO) Q8R4Y4 (/ISO) |
Low-density lipoprotein receptor activity GO:0005041
Combining with a low-density lipoprotein particle and delivering the low-density lipoprotein into the cell via endocytosis.
|
2 | Q8R4Y4 (/ISS) Q8R4Y4 (/ISS) |
Scavenger receptor activity GO:0005044
Combining with any modified low-density lipoprotein (LDL) or other polyanionic ligand and delivering the ligand into the cell via endocytosis. Ligands include acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, beta-amyloid fibrils, and advanced glycation end products (AGEs).
|
2 | Q8R4Y4 (/ISS) Q8R4Y4 (/ISS) |
Hyaluronic acid binding GO:0005540
Interacting selectively and non-covalently with hyaluronic acid, a polymer composed of repeating dimeric units of glucuronic acid and N-acetyl glucosamine.
|
2 | Q8CFM6 (/IDA) Q8CFM6 (/IDA) |
Low-density lipoprotein particle binding GO:0030169
Interacting selectively and non-covalently with a low-density lipoprotein particle, a lipoprotein particle that is rich in cholesterol esters and low in triglycerides, is typically composed of APOB100 and APOE, and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm.
|
2 | Q8R4Y4 (/ISS) Q8R4Y4 (/ISS) |
There are 23 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Positive regulation of lymphangiogenesis GO:1901492
Any process that activates or increases the frequency, rate or extent of lymphangiogenesis.
|
9 | E0CZJ3 (/IMP) E0CZJ3 (/IMP) E0CZJ3 (/IMP) E7EYE0 (/IMP) E7EYE0 (/IMP) F1R1R8 (/IMP) F1R1R8 (/IMP) F6P8Y7 (/IMP) F6P8Y7 (/IMP) |
Blood vessel development GO:0001568
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
|
6 | E7EYE0 (/IGI) E7EYE0 (/IGI) F1R1R8 (/IGI) F1R1R8 (/IGI) F6P8Y7 (/IGI) F6P8Y7 (/IGI) |
Blood vessel development GO:0001568
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
|
6 | E7EYE0 (/IMP) E7EYE0 (/IMP) F1R1R8 (/IMP) F1R1R8 (/IMP) F6P8Y7 (/IMP) F6P8Y7 (/IMP) |
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
|
6 | Q8WWQ8 (/TAS) Q8WWQ8 (/TAS) Q8WWQ8 (/TAS) Q9NY15 (/TAS) Q9NY15 (/TAS) Q9NY15 (/TAS) |
Cell adhesion GO:0007155
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
|
6 | Q8WWQ8 (/NAS) Q8WWQ8 (/NAS) Q8WWQ8 (/NAS) Q9NY15 (/NAS) Q9NY15 (/NAS) Q9NY15 (/NAS) |
Defense response to bacterium GO:0042742
Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
|
6 | Q8WWQ8 (/IDA) Q8WWQ8 (/IDA) Q8WWQ8 (/IDA) Q9NY15 (/IDA) Q9NY15 (/IDA) Q9NY15 (/IDA) |
Blood vessel endothelial cell differentiation GO:0060837
The process in which a relatively unspecialized cell acquires specialized features of a blood vessel endothelial cell, a thin flattened cell that lines the inside surfaces of blood vessels.
|
6 | E7EYE0 (/IMP) E7EYE0 (/IMP) F1R1R8 (/IMP) F1R1R8 (/IMP) F6P8Y7 (/IMP) F6P8Y7 (/IMP) |
Endocytosis GO:0006897
A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.
|
5 | Q8R4U0 (/ISS) Q8R4U0 (/ISS) Q8WWQ8 (/ISS) Q8WWQ8 (/ISS) Q8WWQ8 (/ISS) |
Defense response to bacterium GO:0042742
Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
|
4 | Q8R4U0 (/ISO) Q8R4U0 (/ISO) Q8R4Y4 (/ISO) Q8R4Y4 (/ISO) |
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
|
3 | Q8WWQ8 (/NAS) Q8WWQ8 (/NAS) Q8WWQ8 (/NAS) |
Cell-cell signaling GO:0007267
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
|
3 | Q9NY15 (/IDA) Q9NY15 (/IDA) Q9NY15 (/IDA) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
3 | Q8WWQ8 (/IMP) Q8WWQ8 (/IMP) Q8WWQ8 (/IMP) |
Negative regulation of angiogenesis GO:0016525
Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
|
3 | Q9NY15 (/IMP) Q9NY15 (/IMP) Q9NY15 (/IMP) |
Regulation of blood coagulation GO:0030193
Any process that modulates the frequency, rate or extent of blood coagulation.
|
3 | Q8WWQ8 (/IMP) Q8WWQ8 (/IMP) Q8WWQ8 (/IMP) |
Hyaluronan catabolic process GO:0030214
The chemical reactions and pathways resulting in the breakdown of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
|
3 | Q8WWQ8 (/TAS) Q8WWQ8 (/TAS) Q8WWQ8 (/TAS) |
Endocytosis GO:0006897
A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.
|
2 | Q8CFM6 (/IDA) Q8CFM6 (/IDA) |
Cell-cell signaling GO:0007267
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
|
2 | Q8R4Y4 (/ISO) Q8R4Y4 (/ISO) |
Cell-cell signaling GO:0007267
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
|
2 | Q8R4Y4 (/ISS) Q8R4Y4 (/ISS) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | Q8R4U0 (/ISO) Q8R4U0 (/ISO) |
Negative regulation of angiogenesis GO:0016525
Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
|
2 | Q8R4Y4 (/ISO) Q8R4Y4 (/ISO) |
Negative regulation of angiogenesis GO:0016525
Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
|
2 | Q8R4Y4 (/ISS) Q8R4Y4 (/ISS) |
Regulation of blood coagulation GO:0030193
Any process that modulates the frequency, rate or extent of blood coagulation.
|
2 | Q8R4U0 (/ISO) Q8R4U0 (/ISO) |
Defense response to bacterium GO:0042742
Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
|
2 | Q8R4Y4 (/ISS) Q8R4Y4 (/ISS) |
There are 10 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
6 | Q8WWQ8 (/TAS) Q8WWQ8 (/TAS) Q8WWQ8 (/TAS) Q9NY15 (/TAS) Q9NY15 (/TAS) Q9NY15 (/TAS) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
6 | Q8WWQ8 (/IDA) Q8WWQ8 (/IDA) Q8WWQ8 (/IDA) Q9NY15 (/IDA) Q9NY15 (/IDA) Q9NY15 (/IDA) |
Endocytic vesicle membrane GO:0030666
The lipid bilayer surrounding an endocytic vesicle.
|
6 | Q8WWQ8 (/TAS) Q8WWQ8 (/TAS) Q8WWQ8 (/TAS) Q9NY15 (/TAS) Q9NY15 (/TAS) Q9NY15 (/TAS) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
5 | Q8R4U0 (/ISS) Q8R4U0 (/ISS) Q8WWQ8 (/ISS) Q8WWQ8 (/ISS) Q8WWQ8 (/ISS) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
4 | Q8R4U0 (/ISO) Q8R4U0 (/ISO) Q8R4Y4 (/ISO) Q8R4Y4 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
3 | Q8WWQ8 (/IDA) Q8WWQ8 (/IDA) Q8WWQ8 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | Q8R4Y4 (/ISO) Q8R4Y4 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
2 | Q8R4U0 (/ISO) Q8R4U0 (/ISO) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
2 | Q8R4Y4 (/ISS) Q8R4Y4 (/ISS) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
2 | Q8CFM6 (/IDA) Q8CFM6 (/IDA) |